Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,056,670    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $64,995,519      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 28 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-28 4 AS $81.27 $4,875,990 D/D (60,000) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-07 4 AS $82.52 $5,776,435 D/D (70,000) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-08 4 AS $82.83 $5,797,806 D/D (70,000) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-16 4 AS $90.97 $3,790,795 D/D (41,670) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-27 4 OE $14.39 $14,390 D/D 1,000 324,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-05 4 AS $93.37 $280,114 D/D (3,000) 324,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-08 4 AS $91.27 $275,598 D/D (3,000) 324,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-10-14 4 AS $89.89 $359,560 D/D (4,000) 324,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-11 4 OE $14.39 $14,390 D/D 1,000 325,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-12 4 AS $89.12 $356,480 D/D (4,000) 325,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-16 4 OE $21.51 $21,510 D/D 1,000 326,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-26 4 AS $82.44 $248,640 D/D (3,000) 326,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-02-13 4 OE $67.81 $406,860 D/D 6,000 326,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-30 4 A $68.78 $21,254 D/D 309 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-08 4 AS $82.16 $328,625 D/D (4,000) 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-09 4 AS $81.97 $327,888 D/D (4,000) 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-10 4 AS $82.52 $825,193 D/D (10,000) 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-11-05 4 GD $0.00 $0 D/D 450 327,070 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-11-11 4 A $75.38 $754 D/D 10 327,080 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-11-22 4 AS $77.60 $776,000 D/D (10,000) 327,080 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-25 4 OE $14.39 $57,560 D/D 4,000 327,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-05 4 OE $14.39 $43,170 D/D 3,000 327,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-08 4 OE $14.39 $43,170 D/D 3,000 327,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-09-27 4 OE $21.51 $21,510 D/D 1,000 327,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-10-25 4 AS $69.55 $347,750 D/D (5,000) 327,520 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28  29   30   31   32   33   34   35      
  Page 28 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us